Key facts
- It has raised $2.9M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Norte Ventures, IDB Lab, Inter-American Development Bank, Alexia Ventures, Endeavor Promessas — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Level AI (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Level AI (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Level AI (Enterprise Systems (Healthcare))
Operator of a healthtech company intended to organize clinical and financial data and transform every decision into measurable results. The company's platform helps with hidden revenue identification, protocol automation, risk stratification, a predictable pipeline and reduces costs, enabling health insurance companies, clinics and diagnostic networks to help make financial decisions.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2018
- Employees
- 40
- Website
- levelai.com.br/
- Ownership
- Privately Held (backing)
Level AI (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Level AI (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Level AI (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.